Document Detail


The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis.
MedLine Citation:
PMID:  630934     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Three patients with bacterial endocarditis (one case due to Staphylococcus aureus and two to S epidermidis) failed to improve on standard therapeutic regimens which were judged adequate by in vitro testing for sensitivity. Rifampin was added to the regimen in each case and resulted in increased bactericidal activity in the serum, sterilization of the cardiac valves, and clinical cure. The apparent clinical success that was achieved suggests that further investigation of the effectiveness of therapy with rifampin in selected cases of staphylococcal endocarditis is warranted.
Authors:
R M Massanari; S T Donta
Related Documents :
21814474 - Spinal intramedullary cysticercosis: a case report and literature review.
3457624 - Fusarium. a newly recognized fungal pathogen in immunosuppressed patients.
6694434 - Aerococcus viridans endocarditis.
6083624 - Strut fracture in the björk-shiley mitral valve prosthesis--two case reports.
15914314 - Beyond resinable doubt?
18627714 - The post-thrombotic syndrome - a condition to prevent.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Chest     Volume:  73     ISSN:  0012-3692     ISO Abbreviation:  Chest     Publication Date:  1978 Mar 
Date Detail:
Created Date:  1978-05-17     Completed Date:  1978-05-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0231335     Medline TA:  Chest     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  371-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Endocarditis, Bacterial / drug therapy*
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged
Oxacillin / therapeutic use
Rifampin / therapeutic use*
Staphylococcal Infections / drug therapy*
Vancomycin / therapeutic use
Chemical
Reg. No./Substance:
13292-46-1/Rifampin; 1404-90-6/Vancomycin; 66-79-5/Oxacillin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human alveolar macrophage proteolytic enzyme activities in chronic obstructive pulmonary disease. La...
Next Document:  Delayed peak of the posterior wall. A new echocardiographic index of posterior wall aneurysm.